Mylan launches Remdesivir’s generic version ‘Desrem’ for Covid-19 patients in India
Mylan launches Remdesivir’s generic version ‘Desrem’ for Covid-19 patients in India
Mylan will manufacture DESREM™ in its state-of-the-art injectable facility in Bangalore, which will work to service the demand in India and other export markets where Mylan has received a license from Gilead for the commercialisation of Remdesivir.